Floatz logo

177lu-rad202

HER2 Gene Mutation

Radiopharm Theranostics, LtdEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the HER2 Gene Mutation cohort.

Asset / SponsorPhaseRating
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Intergroupe Francophone de Cancerologie Thoracique
Phase 2B
Eloxatin
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 2/3B
Docetaxel
Intergroupe Francophone de Cancerologie Thoracique
Phase 2B
TRASTUZUMAB
Intergroupe Francophone de Cancerologie Thoracique
Phase 2B
iah0968
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 2/3B

View all 15 →

Same molecule, other indications

177lu-rad202 is also rated in:

cancerDormant
C
Indicative ·
33 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →